These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8303606)

  • 1. [Results of using Aredia for hypercalcemia in oncology patients].
    Lichinitser MR; Vyshinskaia GV; Kupchan DZ; Liubimova NV
    Ter Arkh; 1993; 65(9):80-1. PubMed ID: 8303606
    [No Abstract]   [Full Text] [Related]  

  • 2. Ibandronate in oncology.
    Burckhardt P
    Cancer; 1997 Oct; 80(8 Suppl):1696-8. PubMed ID: 9362439
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bisphosphonates. Drugs for the treatment of disorders of calcium and bone metabolism].
    Warneke G; Henning HV
    Internist (Berl); 1992 Jun; 33(6):441-5. PubMed ID: 1385800
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonates--role in cancer therapies.
    Mehrotra B
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract]   [Full Text] [Related]  

  • 5. Parenteral diphosphonates for treating malignant hypercalcemia.
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Cancer; 1981 Oct; 48(8):1922-5. PubMed ID: 6456809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
    [No Abstract]   [Full Text] [Related]  

  • 7. Denosumab for the treatment of bisphosphonate-refractory hypercalcemia.
    Boikos SA; Hammers HJ
    J Clin Oncol; 2012 Oct; 30(29):e299. PubMed ID: 22949145
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biphosphonates in oncology].
    Khosravi Shahi P; Díaz Muñoz de la Espada V
    An Med Interna; 2005 Nov; 22(11):544-7. PubMed ID: 16454591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial on ibandronate in patients with tumor-associated hypercalcemia].
    Wang T; Song ST; Jiang ZF; Bian SG; Wang YJ; Li LQ; Zhu J
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):739-41. PubMed ID: 15733393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of 18 breast cancer patients with hypercalcemia].
    Masuda N; Yayoi E; Furukawa J; Maruhashi S; Tokunaga M; Takiguchi S; Matsui S; Yano H; Tateishi H; Kinuta M; Maruyama H; Okamura J
    Gan To Kagaku Ryoho; 1998 May; 25(6):845-51. PubMed ID: 9617323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypercalcemia in breast cancer].
    Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC; Schfirin BS
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor 'flare' hypercalcemia--an additional indication for bisphosphonates?
    Nikolic-Tomasević Z; Jelic S; Popov I; Radosavljević D; Mitrović L
    Oncology; 2001; 60(2):123-6. PubMed ID: 11244326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.
    Hassan BA; Yusoff ZB; Hassali MA; Othman SB; Weiderpass E
    Asian Pac J Cancer Prev; 2012; 13(9):4373-8. PubMed ID: 23167346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iv dichloromethylene diphosphonate in cancer-associated hypercalcemia: a phase I-II evaluation.
    Cohen AI; Koeller J; Davis TE; Citrin DL
    Cancer Treat Rep; 1981; 65(7-8):651-3. PubMed ID: 6454484
    [No Abstract]   [Full Text] [Related]  

  • 16. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
    Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S
    Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonates in the treatment concept of metastatic breast carcinoma].
    Possinger K; Flath B; Akrivakis K
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M91-4. PubMed ID: 8964444
    [No Abstract]   [Full Text] [Related]  

  • 18. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
    Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
    Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyrocalcitonin, betamethasone and hydration in hypercalcemia caused by bone metastases of breast carcinoma].
    Azzoini P
    Clin Ter; 1981 Apr; 97(2):147-52. PubMed ID: 7237955
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
    Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.